Increased cerebrospinal fluid corticotropin-releasing factor concentrations during tryptophan depletion in healthy adults

Biological Psychiatry

Volumn 56, Issue 7, 2004, Pages 531-534

  Tyrka, Audrey R ^a,e   Carpenter, Linda L ^a   McDougle, Christopher J ^b   Kirwin, Paul D ^c   Owens, Michael J ^d   Nemeroff, Charles B ^d   Strong, David R ^a   Price, Lawrence H ^a  

^a BROWN UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BUTLER HOSPITAL   (United States)

Author keywords

Cerebrospinal fluid; corticotropin releasing factor; CRF; CSF; depression; HPA; hypothalamic pituitary adrenal; neuroendocrine; tryptophan depletion

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; SEROTONIN; TRYPTOPHAN;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MOOD DISORDER; NERVE CELL; NORMAL HUMAN; PERISTALTIC PUMP; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STATISTICAL SIGNIFICANCE;

ADULT; ANALYSIS OF VARIANCE; CATHETERS, INDWELLING; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MONITORING, PHYSIOLOGIC; PITUITARY-ADRENAL SYSTEM; REFERENCE VALUES; SEROTONIN; TRYPTOPHAN;

EID: 4644283080     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2004.06.035     Document Type: Article

References (29)

1. L. Arborelius, M.J. Owens, P.M. Plotsky, C.B. Nemeroff The role of corticotropin-releasing factor in depression and anxiety disorders J Endocrinol 160 1999 1 12
2. C.M. Banki, G. Bissette, M. Arato, L. O'Connor, C.B. Nemeroff Cerebrospinal fluid corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia Am J Psychiatry 144 1987 873
3. C. Benkelfat, M.A. Ellenbogen, P. Dean, R.M. Palmour, S.N. Young Mood-lowering effect of tryptophan depletion Enhanced susceptibility in young men at genetic risk for major affective disorders Arch Gen Psychiatry 51 1994 687 697
4. L.L. Carpenter, G.M. Anderson, G.H. Pelton, J.A. Gudin, P.D. Kirwin, L.H Price Tryptophan depletion during continuous CSF sampling in healthy human subjects Neuropsychopharmacology 19 1998 26 35
5. F. Chaouloff Serotonin, stress and corticoids J Psychopharmacol 14 2000 139 151
6. M.D. De Bellis, P.W. Gold, T.D. Geracioti, S.J. Listwak, M.A. Kling Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression Am J Psychiatry 150 1993 656 657
7. P.L. Delgado, D.S. Charney, L.H. Price, G.K. Aghajanian, H. Landis, G.R. Heninger Serotonin function and the mechanism of antidepressant action Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan Arch Gen Psychiatry 47 1990 411 418
8. P.L. Delgado, L.H. Price, H.L. Miller, R.M. Salomon, J. Licinio, J.H Krystal Rapid serotonin depletion as a provocative challenge test for patients with major depression: Relevance to antidepressant action and the neurobiology of depression Psychopharmacol Bull 27 1991 321 330
9. M. Deuschle, B. Hamann, C. Meichel, B. Krumm, F. Lederbogen, A Kniest Antidepressive treatment with amitriptyline and paroxetine: Effects on saliva cortisol concentrations J Clin Psychopharmacol 23 2003 201 205
10. T.G. Dinan Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function Life Sci 58 1996 1683 1694
11. M.D. Fossey, R.B. Lydiard, J.C. Ballenger, M.T. Laraia, G. Bissette, C.B. Nemeroff Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects Biol Psychiatry 39 1996 703 707
12. T.D Geracioti Jr, D.N. Orth, N.N. Ekhator, B. Blumenkopf, P.T. Loosen Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans J Clin Endocrinol Metab 74 1992 1325 1330
13. I.J. Heuser, U. Schweiger, U. Gotthardt, J. Schmider, C.H. Lammers, M Dettling Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects Am J Psychiatry 153 1996 93 99
14. F. Holsboer Stress, hypercortisolism and corticosteroid receptors in depression: Implications for therapy J Affect Disord 62 2001 77 91
15. W.J. Inder, T.C. Prickett, R.T. Mulder, R.A. Donald, P.R. Joyce Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine Psychopharmacology (Berl) 156 2001 73 78
16. P.D. Kirwin, G.M. Anderson, P.B. Chappell, L. Saberski, J.F. Leckman, T.D Geracioti Assessment of diurnal variation of cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in healthy human females Life Sci 60 1997 899 907
17. T. Klaassen, W.J. Riedel, A. van Someren, N.E. Deutz, A. Honig, H.M. van Praag Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders Biol Psychiatry 46 1999 489 497
18. M.A. Kling, M.D. DeBellis, D.K. O'Rourke, S.J. Listwak, T.D. Geracioti, I.E McCutcheon Diurnal variation of cerebrospinal fluid immunoreactive corticotropin-releasing hormone levels in healthy volunteers J Clin Endocrinol Metab 79 1994 233 239
19. C.A. Lowry Functional subsets of serotonergic neurones: Implications for control of the hypothalamic-pituitary-adrenal axis J Neuroendocrinol 14 2002 911 923
20. M.A. Magiakou, G. Mastorakos, E. Webster, G.P. Chrousos The hypothalamic-pituitary-adrenal axis and the female reproductive system Ann N Y Acad Sci 816 1997 42 56
21. A.J. Mitchell The role of corticotropin releasing factor in depressive illness: A critical review Neurosci Biobehav Rev 22 1998 635 651
22. F.A. Moreno, C. McGavin, P. Malan, A.J. Gelenberg, G.R. Heninger, A.A Mathe Tryptophan depletion selectively reduces CSF 5-HT metabolites in healthy young men: Results from single lumbar puncture sampling technique Int J Neuropsychopharmacol 3 2000 277 283
23. T. Nickel, A. Sonntag, J. Schill, A.W. Zobel, N. Ackl, A Brunnauer Clinical and neurobiological effects of tianeptine and paroxetine in major depression J Clin Psychopharmacol 23 2003 155 168
24. W. Pitchot, C. Herrera, M. Ansseau HPA axis dysfunction in major depression: Relationship to 5-HT(1A) receptor activity Neuropsychobiology 44 2001 74 77
25. R.J. Porter, P. Gallagher, S. Watson, A.H. Young Corticosteroid-serotonin interactions in depression: A review of the human evidence Psychopharmacology (Berl) 173 2004 1 17
26. L.H. Price, R.T. Malison, C.J. McDougle, E.F. McCance-Katz, K.R. Owen, G.R. Heninger Neurobiology of tryptophan depletion in depression: Effects of m-chlorophenylpiperazine (mCPP) Neuropsychopharmacology 17 1997 342 350
27. L.H. Price, R.T. Malison, C.J. McDougle, G.H. Pelton, G.R. Heninger The neurobiology of tryptophan depletion in depression: Effects of intravenous tryptophan infusion Biol Psychiatry 43 1998 339 347
28. C. Schule, T. Baghai, P. Zwanzger, R. Ella, D. Eser, F Padberg Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine Psychopharmacology (Berl) 166 2003 271 275
29. K.A. Smith, J.S. Morris, K.J. Friston, P.J. Cowen, R.J. Dolan Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion Br J Psychiatry 174 1999 525 529